Caplight Directory>Companies>Lento Bio, Inc.-preview>Lentobio


Lento Bio, Inc.

Lento Bio, Inc.

Private
Syracuse, New YorkHealthcare & Life Scienceshttps://lentobio.com

Last Round

Seed

Sep 6, 2022

Total Funding Raised

$680,000

Momentum Score

50 /100

Company Overview

Lento Bio, Inc. is a biotechnology company developing small-molecule eyedrops to treat presbyopia by restoring ocular lens flexibility.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

presbyopia treatmenttherapeutic eyedropophthalmology therapeuticssmall molecule drugsadvanced glycation end-productsAGEsdisease-modifying therapyAGE breakerlongevity biotechanti-glycation platformlens stiffeningage-related diseasesmolecular damage repairpreclinical biotechdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lento Bio, Inc. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lento Bio, Inc. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 6, 2022
View all Funding Rounds

Key People

Founding team and executive leadership

Kris Barnes

Chief Executive Officer

Executive Team

Lento Bio, Inc. Investors

Notable investors and investment history

InvestorRounds
Richmond View VenturesSeed
View all Investors

Lento Bio, Inc. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lento Bio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lento Bio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSyracuse, New York
Employee Range3
Year Founded2022
Last FundingSep 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.